BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18089679)

  • 1. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
    Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
    Zhang X; Shu H; Zhang F; Tian X; Dong Y
    Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
    Kelly MC; Denburg JA
    J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y; Yanagida T; Hirohata S
    Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
    Bassi N; Ghirardello A; Blank M; Zampieri S; Sarzi-Puttini P; Mantovani A; Shoenfeld Y; Doria A
    Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
    Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
    J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
    Trysberg E; Nylen K; Rosengren LE; Tarkowski A
    Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
    Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.